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ABSTRACT : The effect of thymectomy on elimination of a myasthenic symptom 
was clinically evaluated. The operative approach was primarily extended thy-
mectmy of choice via midsternotomy in all but one of transcervical approaches. 
Most of them belonged to Osserman II b and II a of the disease type. 
   Thirteen cases were in combination with thymoma and thirty-five were not in 
combination. Thymectomy yields a 53.8% effectiveness rate for patients with thy-
moma and a 65.7% for patients without thymoma. There was no defenitive relation-
ship between the operation effectiveness and the suffering duration of time. However, 
aggravation and no improvement of a clinical sign after thymectomy were observed 
in patients with a severe or moderate degree of germinal center formation.
       INTRODUCTION 
 Great strides in the field of thoracic surgery 
as well as in the knowledge of respiratory care 
have been achieved. Thymectomy has been done 
safly with refined technique and meticulous 
postoperative cares. Therefore, thymectomy 
has become the first choice of treatment for 
myasthema gravis. 
 The aim of this study is to evaluate the 
efficacy of thymectomy for myasthenia gravis 
on the basis of a result of clinical experience.
          Table 1. Patients 
AGE MALE FEMALE TOTAL 
 ^-19 1 1 
20^- 6 5 11 
30- 1 10 11 
40- 6 12 18 
50- 1 2 3 
60- 2 2 
70- 1 1 2 
       15 (37.6) 33 (39.6) 48 (38.9)
         PATIENTS 
 During the past 23-year period from January 
1965 to December 1987, 48 thymectomy for 
myasthenia gravis were clinically analyzed. 
Females were predominant in a ratio of 15 : 33 
according to the distribution of sex in this 
group as shown in Table 1.
 Age distribution showed a peak in the 4th 
decade, followed by the 2nd and 3rd decade in 
the order. According to OSSERMAAr's cla sifica-
tion, most were If b and/or II a and a few were 
I and/or III. Thirteen were accompanying thy-
moma and thirty-five were non-thymoma. The 
suffering period from onset in most cases were 
2 to 4 year duration, ranging from 3 months 
to 18 years and 3 months, as shown in Fig. 1. 
 As for an operative approach, midsternotomy
was applied in 44 patients, right thoracotomy 
in 3 including 2 cases in whom pulmonary 
resections were cobined and transcervical 
approach in 1. Thymectomy yielded a favorable 
result of improvement in 53.8% of patients 
with thymoma, in contrast, in 65.7% of pa-
tients without thymoma as shown in Table 3. 
 The suffering periods from onset were com-
pared and improvement was obtained from the 
period from 6 months to 3 years. However, 
aggravation was also seen regardless of the 
suffering period of disease. No change in clini-
cal sign is seen in patients with short and long 
suffering periods, and efficacy of thymectomy 
did not reveal a constant outcome with vary-
ing variety. As shown in Table 4, in all the 4 
patients in whom a clinical sign was aggravat-
ed following thymectomy demonstrated a 
histologically significant formation of 
germinal centers and 10 out of 14, in whom 
clinical sign did not change nor improved,
Table 2. Disease stage classification Osserman 
       classification 
Osserman type Male Female Total 
     I 4 1 5 
    IIa 8 12 20
    lI b 2 19 21 
     II[ 1 1 .2
             15 33 48
Fig. 1. Suffering period from onset
        Table 3. Efficasy of thymectomy for myasthenia gravis 
                   with thmoma without thymoma total 
complete remission 1 4 5 
improvement 6(53.8%) 19(65.7%) 25(62.5%) 
no change 3 11 14 
aggravation 3 1 4
showed moderate or severe degrees of germi-
nal center formation by histologic examination. 
Furthermore, a long-term prognosis closely 
correlated with the degree of histologically con-
firmed germinal center formation. 
        DISCUSSION
 Since Blalock first reported that thymectomy 
for myasthenia gravis yielded favorable result, 
thymectomy has been prevalent for the treat-
Table 4. Relationship between effect of thymec 
        tomy and gerninal center 
                           germinal 
                   no slight moderate severe 
complete remission 5 3 1 1 
improvement 25 18 5 2 
no change 14 4 4 6 
aggravation 4 4
ment of myasthenia gravis. It was accepted 
that thymectomy is of great benefit for pa-
tients with thymoma or abnormal formation 
of germinal center, as proved by histologic 
examination. 
 It is believed that the thymic gland plays an 
important role in regulation of the immune 
response to the host with intricated activa-
tions with variety. However, it is not clear as 
to what kinds of mechanisms act to cause
Fig. 2. Efficasy of thymectomy for myasthenia 
       Gravis in relation to suffering period
muscle weakness in the pathogenesis of mya-
sthenic gravis. 
  In 1970, transcervical approach was recom-
mended for thymectomy to minimize postoper-
ative complications, damage to respiratory 
function ' as well as to enhance cosmetic 
effects. However, it has become clear that 
surgical outcome of transcervical approach is 
unsatisfactory as compared with that of mid-
sternotomy. Since that time, extended thy-
mectomy has been recommended. It includes 
complete resection of fatty tissues that means 
a removal of aberrant thymic tissures among 
the fatty tissues in the anterior mediastinum. 
A favorable outcome of surgery is reported as 
being delayed remission. It showed improve-
ment of 50% for 5 years in non-thymoma pa-
tients with improvement year by year, although 
an efficiency of thymectomy reaches 80% at 3 
months and 90% at 1 year, in contrast to 70% 
at 3 month in thymoma patients, demonstrat-
ing a remarkable improvement at an early 
stage. 
 These results are superior to those obtained 
by drug therapies and it is helpful to eliminate 
a needed dosis of drugs. It is well known that 
patients aged over 40 years is not necessarily a 
suitable candidate for thymectomy. PALETTo 6 
reported that thymectomy in childhood holds 
promise of a satisfactory result. 
. In this series, age is not a handicap to yield 
a satisfactory result of surgery. The fact that 
the longer the suffering period, the less the 
effect of surgery, may be true because surgical 
outcome closely correlate with the intensity of 
histological germinal center formation. 
 It is widely accepted that antiacetylcholin 
receptor antibody plays a key role in patients 
with myasthema gravis. The germinal center 
is composed of B-cells. On the other hand, T-
cells are differentiated by the help of a fun-
ction of the thymic gland, although it is not 
so forceful. From the above facts, it is 
reasoned that thymectomy for myasthenia 
gravis is of help to eliminate or improve a 
clinical sign. It is a reflection of an efficacy 
of thymectomy that leads to reduction of the 
level of antiacetylcholin receptor antibody. It 
is very difficult to determine preoperative 
expectation of the effect of thymectomy on
 myasthenia gravis. 
  It is defined that myasthenia gravis accom-
 panys functional abnormality of the thyroid 
 and parathyroid glands and its pathogenesis is 
 much complex. Surgeons should be borne , in 
 mind that aberrant thymic gland tissue in the 
 fatty tissues of the anterior mediastinum
 more frequently hold a tumor and extended 
 thymectomy is mandatory for better surgical 
 outcome. 
   In this study, there was no experience with 
 the patients in whom the clinical sign was 
 aggravated following surgery as well as in 
 whom reoperation was reqiured. It is emphasiz-
 ed to cite that accurate detection of the pres-
 ence of aberrant thymic gland is of great 
 value to make surgical outcome much more 
 favorable. 
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